Novo Nordisk on Tuesday received a broker downgrade, with the analysts arguing that its status as a duopoly in both diabetes and weight loss are under threat.
Category: Business
Post
Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute
Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
Post
The guards rise again: the force still shaping Iran
Should the regime survive, hardliners believe the IRGC’s influence will be ever greater
Post
The bombing of Tehran — in maps and satellite images
Israeli and US strikes have targeted regime infrastructure and also struck civilian sites. Here are some of the key buildings hit
Post
Qatar warns war will force Gulf to stop energy exports within weeks
Gas producer says it will take ‘weeks to months’ to restore deliveries after Iranian drone strike
Post
Nvidia stops production of chips intended for Chinese market
US group moves production away from H200s to latest Vera Rubin products
Post
A Blackstone executive made a revealing comment about the state of private credit
A Blackstone executive made a revealing comment about the state of private credit. Analysts are now reverse engineering its implications.